Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jul 27, 2023; 15(7): 1388-1396
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1388
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1388
β | OR (95%CI) | P value | |
Risk factors for major complication | |||
Obstructed jaundice | 1.902 | 6.698 (1.133-39.596) | 0.036 |
Fibrinogen < 2 g/L | 2.846 | 17.226 (2.647-112.102) | 0.003 |
Prebiopsy application of anticoagulants/antiplatelet medications | 3.181 | 24.078 (1.678-345.495) | 0.019 |
Postbiopsy hemoglobin level | -0.037 | 0.963 (0.942-0.985) | 0.001 |
Age | 0.091 | 1.096 (1.012-1.187) | 0.025 |
Risk factors for all-cause 30-d mortality | |||
Prebiopsy hemoglobin | -0.038 | 0.963 (0.928-0.999) | 0.042 |
Postbiopsy hemoglobin | -0.043 | 0.958 (0.930-0.987) | 0.005 |
- Citation: Chai WL, Lu DL, Sun ZX, Cheng C, Deng Z, Jin XY, Zhang TL, Gao Q, Pan YW, Zhao QY, Jiang TA. Major complications after ultrasound-guided liver biopsy: An annual audit of a Chinese tertiary-care teaching hospital. World J Gastrointest Surg 2023; 15(7): 1388-1396
- URL: https://www.wjgnet.com/1948-9366/full/v15/i7/1388.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i7.1388